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ABSTRACT 
Membrane proteins (MP) are important drug discovery targets for a wide range of 
diseases. However, elucidating the structure and function of native MP is notoriously 
challenging as their original structure has to be maintained once removed from the 
lipid bilayer. Conventionally detergents have been used to solubilize MP with varying 
degrees of success concerning MP stability. To try to address this, new more 
stabilizing agents have been developed such as calixarene-based detergents and 
styrene maleic acid co-polymer (SMA). Calixarene based detergents exhibit enhanced 
solubilizing and stabilizing properties compared to conventional detergents, whereas 
SMA is able to extract membrane proteins with their surrounding lipids forming a 
nanodisc structure. Here we report a comparative study using classical detergents, 
calixarene based detergents and SMA to assess the solubilization and stabilization of 
the human ABC transporter MRP4 (multidrug resistance protein 4/ABCC4). We show 
that both SMA and calixarene based detergents have a higher solubility efficiency (at 
least 80%) than conventional detergents and show striking overstabilization features 
of MRP4 (up to 70°C) with at least 30°C stability improvement in comparison to the 
best conventional detergents. These solubilizing agents were successfully used to 
purify aggregate free homogenous and stable MRP4, with 7-fold higher yield for 
C4C7 Calixarene detergent in comparison to SMA. This work paves the way to 
MRP4 structural and functional investigations and illustrates once more the high 
value of using Calixarene based detergent or SMA as versatile and efficient tools to 
study MP and eventually enable drug discovery of challenging and highly druggable 
targets. 
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 INTRODUCTION 
Membrane proteins (MP) are capable of controlling what enters and exits cells 
through transporters and channels, modulating cell signalling with receptors, 
catalysing reactions by utilizing enzymes and maintaining structure with anchoring 
proteins. Membrane proteins are highly valuable pharmaceutical targets and 
understanding the structure and function of these important proteins is vital in the 
production of beneficial pharmaceutical drugs. Observing membrane proteins in their 
native state is the most useful for producing effective pharmaceutical drugs, as there 
have been no modifications to the native structure. Unfortunately, membrane proteins 
are not stable outside of the native lipid environment. In order to gain a true 
understanding of how membrane proteins are structured and function they must be 
viewed in isolation (purified). This means producing a highly stable membrane 
protein that retains its native structure through purification processes and is able to be 
used in functional and structural studies. To overcome this stability problem 
membrane proteins have often been altered either by changing the native amino acid 
sequence through protein mutagenesis or engineering1. Antibodies have also been 
used in efforts to stabilize membrane protein2 but all these methods come with a price, 
they might alter the native conformation of the membrane protein. Investigating 
membrane proteins in their native state is challenging as they often become highly 
unstable when solubilized with. Solubilization reagents are available in a range of 
strengths form harsh anionic detergents such as SDS and Sarkosyl, mild zwitterionic 
detergents, Fos-Cholines (FC) and CHAPS, to weaker non-ionic detergent such as 
dodecylmaltoside (DDM) and octyl glucoside (OG). All these contain a similar 
structure with a hydrophobic acyl tail and a hydrophilic head group allowing them to 
act as amphiphiles removing the lipids surrounding the membrane protein. In doing 
so, they are removing the lateral pressure exerted by the lipids keeping the membrane 
protein in its correct conformation and replacing it with much less stable detergents. 
Although these conventional detergents have been used for membrane protein studies, 
success rate is variable and is largely protein dependent. Novel detergents have 
therefore been produced in an effort to stabilize a much greater variety of membrane 
proteins. 
Many of these novel detergents are built on previous conventional detergents utilizing 
their solubilization capabilities but also enhancing their stabilizing properties. MNG 
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(Maltose-Neopentyl Glycol) and GNG (Glucose-Neopentyl Glycol) are two novel 
detergents that have very similar structures to DDM and OG respectively, through the 
addition of a central quaternary carbon atom derived from neopentyl glycol,  two 
hydrophobic and hydrophilic groups can be connected 3. Facial amphiphiles represent 
a slightly different approach to maintaining membrane protein stability. These 
molecules are comprised of a hydrophobic sterol backbone capable of solubilization 
attached to different head groups many of which are maltose based 3. Facial 
amphiphiles have been shown to solubilize and aid in the crystallisation membrane 
proteins 4 and have further been modified to create tandem facial amphiphiles and are 
able to span the width of a lipid bilayer 3.  
Calixarene based detergents have been shown to have a greater ability to stabilize 
membrane proteins 5-6. They contain a calixarene platform comprising of four 
aromatic rings, three in the para position and the fourth attached to the hydrocarbon 
chain 6. By altering the length of the hydrocarbon tail the solubilization properties are 
affected, increasing their efficiency. Different head groups such as carboxylate or 
sulfonate groups can be attached to the calixarene platform. These head groups can 
interact, through the formation of salt bridges, with the aromatic or charged residues 
at the lipid-protein interface creating a more stable membrane protein-detergent 
complex 5. A bacterial ATP Binding Cassette (ABC) transporter, BmrA has 
previously been extracted with C4C7 (calixarene containing 7 carbon length 
hydrocarbon chain) and it maintained 90% function whereas solubilization with DDM 
or FC12 resulted in a 90-99% loss of function. Calixarenes enhance the stability of 
solubilized membrane proteins 5-6.  
A different approach to solubilizing and stabilizing membrane proteins is through the 
use of styrene maleic acid (SMA) co-polymer. This polymer is comprised of 
alternating units of styrene and maleic acid in varying ratios. They are able to insert 
into membranes and solubilize bi-layers forming SMA lipid particles (SMALPs)7-8. 
Membrane proteins can become trapped inside these SMALPs, solubilizing the 
membrane protein and encapsulating it in a disc of its native lipids 8-9 (Figure 1A). 
This is very different from detergent solubilization (Figure 1B). Once solubilized in 
SMA, the membrane protein can be purified without the need for detergents in any of 
the buffers, making it much more cost effective 10-11. These SMA lipid particles 
(SMALP) can also be used in functional studies as both sides of membrane protein 
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are accessible and have been shown to produce highly stable membrane proteins 10, 12. 
SMA has successfully been used to extract a variety of ABC transporters from 
different expression systems 10, 13 along with ligand binding studies of ABC 
transporters and GPCRs 12, functional reconstitution of KscA 11as well as lipid 
analysis. These examples show the versatility of the SMA polymer in aiding 
functional understanding of membrane proteins. SMALP purified proteins have been 
used for structural studies by both crystallography 14 and electron microscopy 10, 15-17.  
Most reported MP structure and function studies describe the use of one main reagent. 
Therefore, a comparative study is very often missing. In the current work, we have 
applied classical detergents, calixarene based detergents and SMA polymers to 
investigate in parallel the solubilization and stabilization of the same MP membrane 
protein target. We have chosen a member of the ABC transporter family 
(ABCC4/MRP4) as a model membrane protein. ABC transporters are integral 
membrane proteins that are found in all types of organisms from prokaryotes to 
humans. They utilize energy from ATP binding and hydrolysis to transport a variety 
of substrates across the biological lipid bilayer 18. MRP4 is made of four core 
domains: two transmembrane domains (TMDs) and two nucleotide binding domains 
(NBD). Each of the two TMDs comprises 6 transmembrane alpha helices and the two 
NBDs have binding sites for ATP which are homologous throughout the super family 
unlike the TMDs 19. As its name suggests MRP4 can confer resistance to drugs 
including cancer chemotherapy, antivirals and antibiotics20. It can also transport 
signalling molecules such as cyclic nucleotides and eicosnaoids making it a drug 
target for inflammation, pain21 and cardiovascular disease22, and it has also been 
implicated in the development of cancer23-24. To date there is no known structure of 
human MRP4. To investigate MRP4 structure and function, it is critical to be express 
it, solubilize it and purify it while maintaining its functionality and structural 
integrity. Here we show that using calixarene based detergent or SMA, allowed the 
purification of very stable, homogenous MRP4.  
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MATERIAL & METHODS 
Expression and Membrane preparation 
Expression of the recombinant human MRP4-his6 within Sf9 cells was conducted 
using a baculovirus encoding for recombinant MRP4 generated from a pFastBac-
MRP4-his6 construct with a C-terminal hexa-his tag. Typically, Sf 9 insect cells 
expression was using the Bac-to-Bac Baculovirus system for 48 hours at MOI of 2. 
Infected Sf 9 cells were harvested by centrifugation at 6000 g for 10 minutes. The cell 
pellet was resuspended in homogenisation buffer (50mM Tris-HCl pH 7.4, 250mM 
Sucrose, 0.25mM CaCl2 and protease inhibitors (1.3µM benzamidine, 1.8µM 
leupeptin and 1µM pepstatin). Homogenisation of Sf 9 cells was carried out using 
nitrogen cavitation at 500 psi for 15 minutes on ice. The cell lysate was centrifuged at 
750 g for 10 minutes, the supernatant was then subsequently centrifuged at 100,000 g 
for 20 minutes. The membrane pellet was resuspended in TSB buffer (50mM Tris-
HCl pH 7.4, 250mM Sucrose) and stored at -80oC. 
 
Solubilization 
SMA polymers were obtained from Cray Valley (SMA 2000) or Polyscope 
(SZ25010) as styrene-maleic anhydride polymers and were hydrolysed in 1M NaOH, 
refluxed and freeze dried to form the styrene-maleic acid form as described in 13.   
Dot blot analysis was carried out by solubilizing MRP4 Sf 9 membranes at 5 mg/mL 
total protein using 10x critical micellar concentration (CMC) of each detergent 
(calixarene based detergents, CALIXAR or conventional detergents, VWR) or 
2.5%(w/v) for SMA polymers, for 2 hours at 4oC. 200μL was loaded into the Dot blot 
apparatus (Biorad), filtered through nitrocellulose and washed with 3 x 200µl PBS to 
remove insoluble material. An anti-his HRP antibody (3:2000, R&D Systems) was 
used to detect MRP4 and quantified on a ChemiDoc imaging system. Solubility 
efficiency was calculated by comparing the density of the dot to an SDS control. 
Western Blot analysis was performed to assess the solubilization efficiency. Sf 9 
MRP4 membranes at 5 mg/mL total protein were solubilized using 10x CMC 
detergent, or 2.5%(w/v) SMA polymer at 4oC for 2 hours then centrifuged at 100,000 
g. The insoluble pellet was resuspended in 1% (w/v) SDS. Samples were run on SDS-
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PAGE and transferred to PVDF membrane and a primary anti-his antibody was used 
to detect MRP4. Solubility efficiency was calculated via densitometry analysis using 
ImageJ or Image Studio analysis software by calculating the intensity of the 
solubilised band as a percentage of the total (soluble + insoluble). Optical density 
(OD) readings were measured on an Ultrospec 2000 spectrophotometer (Pharmacia 
Biotech) at 600nm. 
 
Western blot based thermal shift assay 
Thermostability of solubilized or purified MRP4 was measured by heating samples 
for 10 minutes at different temperatures (4 – 90oC) then centrifuged at 14, 000g for 10 
minutes. The supernatant was removed and analysed by Western Blot. Data fitting 
was performed by fitting a dose (temperature) vs normalised response curve using 
GraphPad Prism. The method was previously described and applied to GPCR 
solubilization 25. 
 
MRP4 Purification 
Sf 9 MRP4 membranes solubilized with 10x CMC Calixarenes were mixed with Ni-
NTA affinity resin at a volumetric ratio of 10 : 1 (soluble MRP4 : resin) for 2 hours at 
4oC. Resin was washed with 3 x 10 column volumes (CV) 5mM Imidazole and eluted 
in 5 x 1 CV using 200 mM imidazole. All purification buffers were supplemented 
with 2 CMC Calixar detergents. MRP4 was concentrated using a 50kDa MWCO spin 
concentrator. 
Affinity purification using SMA polymer was performed using an adapted protocol 
from 13. Sf 9 MRP4 membranes solubilized with 2.5% SMA 2000 were mixed with 
Ni-NTA resin overnight at 4oC a volumetric ratio of 20:1 (soluble MRP4 : resin). 
Resin was washed with 5 x 10 CV 20mM imidazole and eluted in 5 x 1 CV using 200 
mM imidazole. MRP4 was concentrated using a 30 MWCO spin column. 
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RESULTS 
MRP4 solubilization 
We wanted to find out which detergents or polymers were best for both solubilizing 
and stabilizing MRP4. We started by measuring their solubilization properties by 
screening a large range of detergents and SMA polymers monitored by dot blot 
(Figure 2A). All conventional detergents screened were able to solubilize around 
50% of MRP4 from Sf 9 cells membranes with the exception of harsh anionic 
Sarkosyl which was equal to SDS. Calixarene detergents tested here had the same 
calix[4]arene platform onto which three acidic methylene-carboxylate groups have 
been grafted at the para position while the other face bears a single aliphatic chain of 
different lengths.  Typically, C4C5, C4C7 and C4C8 correspond to detergents with 5, 
7 and 8 carbons length, respectively.  C4C5, C4C7 and C4C8 were able to solubilize 
over 90% of the MRP4. Anything below (C4C3) or above (C4C10 C4C11 and 
C4C12) decreased the solubilization efficiency by around half and were comparable 
to conventional detergents. The length of the acyl tail in calixarene detergents 
therefore plays a key role in solubilization efficiency. The SMA polymers also had 
high solubilization efficiency with SMA 2000 and SZ25010 both at 100%. These 
results show that novel solubilizing agents are capable of greatly increasing the 
solubilization efficiency of MRP4 when compared to conventional detergents. The 
top conditions with the highest solubility efficiency revealed by dot blot were chosen 
to measure and confirm the solubility efficiency using western blot analysis (Figure 
2B). C4C5 was shown to have a very high solubility efficiency of 90%; C4C7 was at 
76% and C4C8 was at 65% solubility again showing the length of the acyl tail can 
affect solubility efficiency. SMA 2000 and SZ25010 solubility efficiency was at 83 
and 73%, respectively. Only detergent mixtures with harsh conventional detergents 
such as Sarkosyl and FC12 allowed higher solubilization efficiency than Calixarene 
detergents alone. Interestingly the kinetics of MRP4 solubilisation by SMA 2000 
were much faster than is typically reported for SMA polymers 10 (Supplementary 
Figure 1) and it can be seen that the vast majority of solubilisation events occur within 
the first 15 minutes.    
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Thermostability of solubilized MRP4 
Before moving onto purification, the ability of these solubilizing agents to stabilize 
MRP4 was assessed using a previously established western blot based thermal shift 
assay 25. This assay relies on the assumption that unstable heated proteins will 
aggregate and after ultracentrifugation and western blot the band intensity 
corresponding to the protein will decay proportionally to its instability. By measuring 
the amount of MRP4 that remains soluble at increasing temperatures the denaturing 
point (Tm), 50% soluble, can be estimated. MRP4 solubilized using either C4C5 or 
C4C7 showed a very high Tm of around 70oC (Figure 3A). SMA 2000 solubilised 
MRP4 also showed a very high Tm of around 75oC (Figure 3C). The conventional 
detergents chosen all have a similar solubilization percentage and had previously been 
used in studies involving the solubilization of ABC transporters. The Tm for 
conventional detergents ranged from 28 to 40oC with FC 12 being the highest and 
C12E8 the lowest (Figure 3B). Thus, the Tm for MRP4 in the calixarene detergents 
(C4C5 and C4C7) or SMALPs was 30°C or 35°C higher than the best conventional 
detergent for MRP4 stability, respectively.  
 
MRP4 Purification 
To evaluate the impact of solubilization reagents on protein purification, his-tag 
affinity purification was performed for MRP4 solubilized with either C4C7, SMA 
2000 or DDM. Figure 4A shows that MRP4 was specifically loaded and eluted from 
the Ni-NTA affinity column. SDS-PAGE gels demonstrate a relatively pure MRP4 
after one affinity purification step for both C4C7 and SMA 2000 (Figure 4B). 
However, with DDM, the MRP4 is not at all pure, with multiple contaminating bands 
which are equally as intense as the MRP4 band (Figure 4B). Notably C4C7 
consistently gave higher yields of pure protein (184±8 µg/l cell culture) compared to 
SMA 2000 (26±7 µg/l cell culture).  
Native PAGE Western blot analysis (Figure 5) confirmed that one main non-
aggregated population of MRP4 was obtained for both C4C7 and SMA 2000, 
demonstrating the homogeneity and good behavior in solution when SMA 2000 or 
C4C7 were used for solubilization and purification. MRP4 solubilized and purified in 
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C4C7 could easily be concentrated using centriprep centrifugal filter unit without 
generating any aggregates since the MRP4 band became more intense upon 
concentration with no aggregate species observed on the well of the gel (Figure 5A, 
compare lane 2 to 1). For both C4C7 and SMA 2000 storage for 7 days at 4°C had no 
effect on MRP4 aggregation. Similarly, MRP4 showed no changes after freezing and 
thawing steps in C4C7 or SMA 2000. The same aggregate free behavior in solution 
was observed even in absence of cryoprotectant (10% glycerol) (Figure 5).  
The thermostability of purified MRP4 was also examined using the same western blot 
thermal shift assay as previously described. Interestingly, the same tendencies were 
noticed after solubilization and purification of MRP4 (Figure 6). In fact, SMA 2000 
and C4C7 maintained high stability of MRP4 during purification and the Tm 
remained high, 71oC and 65oC respectively (Figure 6A and 6B), whereas MRP4 
solubilized and purified in DDM has a Tm of 49oC (Figure 6C). 
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DISCUSSION 
Here we show that MRP4 was successfully solubilized and purified using both C4C7 
and SMA 2000. Concerning calixarene based detergent, the length of the hydrophobic 
chain controls solubilization efficiency. MRP4 was kept in a very stable state 
compared to the best of the conventional detergents DDM or FC12. Indeed, the 
stabilizing properties of C4C7 and SMA 2000 were demonstratred by a dramatic 
thermostability improvement of 30 and 35°C, respectively at the solubilization step in 
comparison to the best conventional detergents. This stabilization shift is very high 
considering that the MRP4 investigated was full length, wild type without any single 
point mutation. It is very common to heavily mutate membrane proteins to improve 
their thermostability 26. This was the case of for the Adenosine receptor which was 
mutated at 8 residues and had 96 amino-acids at the carboxy-terminal deleted leading 
to ~15°C stability improvement 27. Our results illustrate the fact that there is no need 
to systematically mutate or truncate MPs in order to stabilize them. Using favorable 
chemical environments can impact positively the stability and functionality of MPs. 
The fact that C4C7 detergent exhibits a comparable overstabilizing features in 
comparison to SMA is outstanding considering that in contrast to detergents, SMALP 
particles contain lipids and it is well accepted that lipids exert stabilizing effect on MP 
28. The fact that stability improvement was reduced (to +16 and +22oC for C4C7 and 
SMA, respectively in comparison to DDM) when MRP4 was solubilized and purified 
in comparison to solubilized only, is maybe due to the loss of some key stabilizing 
lipids during the purification process. Further studies including mass spectrometry 
analysis are required to confirm that. Differences in the degree of cooperativity of the 
thermal shift curves were noticed. This was also observed for other MPs using other 
detergents 29. Further studies using other thermostability assays are required to 
explain the contribution of the chemical environment (lipid/ detergent/ polymer) and 
the MP dynamics (in detergent or in SMA) on the shape of thermal shift curves.  
Now that good solubilization and stabilization conditions have been found, structural 
investigation of MRP4 can begin. The next steps would be to use cryo-EM to 
investigate MRP4 structure in solution. Preliminary negative stain electron 
microscopy images showed isolated particles of MRP4 (data not shown). SMA and 
Calixarene based detergent have both previously been shown to be compatible with 
electron microscopy 15-17, 30. It has previously been reported that SMA somehow 
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interferes with binding to Ni2+ resin13, 31-32, and this might explain the difference in 
protein yield. It has also been previously reported that SMA 2000 results in much 
more pure protein samples than conventional detergents10, 33. Here it is shown that 
SMA 2000 gave a good degree of purity following a single step affinity purification, 
but, in contrast to more conventional detergents, C4C7 also gave a comparable degree 
of purity. There were however some limitations found for each approach. Due to its 
calixarene platform, Calixarene detergent absorbs at 280 nm which makes protein 
quantification difficult and limits the use of some biophysical charaterization such as 
Circular Dichroism or tryptophan fluoresence. To adress this limitation, new classes 
of compounds with similar architecture but without the calixarene platform have been 
designed and applied succesfully to MP stabilization 34, and this could be a promising 
future direction for MRP4 studies. The addition of mild groups such as saccharide 
heads or cholesterol like groups provide more diversity for the such class of 
stabilizing detergent 6, 35. Current limitations to the SMA approach include the disc 
size. The typical size is 10-12 nm diameter, which may mean some large proteins or 
protein complexes will not fit. However, recent reports have suggested there is some 
flexibility with this 16. SMA is also sensitive to divalent cations such as magnesium 
and calcium 33. This is particularly problematic for proteins like the ABC transporters 
which require Mg2+ for ATP hydrolysis. Alternative polymers such as styrene 
maleimide SMI and diisobutylene -maleic acid (DIBMA) have also being developed 
which are reported to overcome the divalent cation sensitivity by replacing the maleic 
acid with either maleimide (SMI) or replacing the styrene with diisobutylene 
(DIBMA) 36-37.  
Taken together, we report here that if used for solubilization and purification, C4C7 
and SMA maintain the structural integrity of MRP4. In addition to structural studies, 
these findings open up the possibility of functional and drug discovery approaches 
with MRP4. Calixarenes based detergents and SMA represent important versatile 
tools as part of the fast-growing toolbox to help unlock the drug discovery potential of 
challenging membrane protein targets. This is and will undoubtedly be the case for 
antibody discovery, structure-based drug design and small molecule screening of 
highly druggable membrane proteins  
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FIGURES LEGEND 
Figure 1- Schematic representation of membrane proteins in detergent (A) or in 
Styrene maleic acid (B). Membrane protein helices are represented in blue. SMA, 
phospholipids and detergent are also indicated. 
 
Figure 2- Solubilization of MRP4.  
A- Screening of conventional detergents, Calixarenes and SMA polymers for MRP4 
solubilization analysed by Dot blot using a His-tag antibody. All dots intensities were 
compared to an SDS control. Data are the mean and variation between duplicates. B- 
Solubilization efficiency assessed by western blot for the selected conditions from dot 
blot analysis.  
 
Figure 3- Thermostability of MRP4.  
Thermostability was measured by the percent of soluble MRP4 present after heating. 
A- thermostability of MRP4 solubilized with calixarenes C4C5 and C4C7 from 45 to 
95oC (n=2). B- Conventional detergent thermostability from 4 to 90oC (n=2). C- 
thermostability results for MRP4 solubilized with SMA2000 from 40 to 89oC (n=2). 
The Tm was calculated as the temperature at which 50% remained soluble. Dose 
(temperature) vs normalised response curve fitted for all graphs.  Data represent the 
mean and the variation between duplicates. 
 
Figure 4- MRP4 purification.  
A- Western blot showing His-tag affinity purification of MRP4 after solubilization 
using C4C7, SMA 2000 or DDM. B- Instant Blue stained SDS-PAGE of purified 
MRP4 using C4C7, SMA 2000 or DDM.  
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Figure 5- Native gel analysis. 
 Native PAGE and western blot analysis to assess the behavior in solution of MRP4 
purified with C4C7 (A) or SMA 2000 (B). Examined after protein concentration using 
centrifugal filter concentrators, storage at 4°C for 7 days or after freezing/ thawing 
steps. +Gly corresponds to the addition to 10% Glycerol before freezing and thawing 
steps. 
 
Figure 6- Thermostability of purified MRP4. 
 Thermostability curves of MRP4 purified in SMA (A), C4C7 (B) and DDM (C) 
respectively, based on percent soluble after heating and centrifugation (n=3 ±SEM). 
The blue line represents the transition/melting point (Tm), the temperature at with 
50% of MRP4 is still soluble as previously described 25 . Western blots below graph 
A, B and C show examples of amounts of soluble MRP4 at each temperature in SMA, 
C4C7 and DDM respectively. The density of each of the band was taken and 
compared to the 4oC control to calculate the percent soluble.  
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Supplementary Figure 1: Kinetics of MRP4 solubilisation with SMA 2000. 
The solubilisation of MRP4 expressing Sf9 cell membranes at room 
temperature was monitored over time by measuring both the turbidity/OD600 
(closed circles) to monitor general membrane disruption, and Western blotting 
to measure MRP4-specific solubilisation (open circles). It can be seen that the 
solubilisation was quick, and essentially complete after 15 minutes. 
 
 
